Suchergebnisse - "YO603Y8113"

PubPharm (159)

1

Safety and efficacy of doravirine as first-line therapy in adults with HIV-1 : week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials

enthalten in: The lancet. HIV | 2024

von Orkin, C. | Molina, J. | Cahn, P. | +112

2

A detailed characterization of drug resistance during darunavir/ritonavir monotherapy highlights a high barrier to the emergence of resistance mutations in protease but identifies alternative pathways of resistance

enthalten in: The Journal of antimicrobial chemotherapy | 2024

von Abdullahi, A. | Diaz, A. | Fopoussi, O. | +5

3

Changes in Cerebrospinal Fluid, Liver and Intima-media-thickness Biomarkers in Patients with HIV-associated Neurocognitive Disorders Randomized to a Less Neurotoxic Treatment Regimen

enthalten in: Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology | 2023

von Stroffolini, G. | Lazzaro, A. | Barco, A. | +9

4

Bioequivalence of a Pediatric Fixed-Dose Combination Tablet Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Compared With Coadministration of the Separate Agents in Healthy Adults : An Open-Label, Randomized, Replicate Crossover Study

enthalten in: Clinical pharmacology in drug development | 2023

von Van Hemelryck, S. | Van Landuyt, E. | Ariyawansa, J. | +2

5

HIV-DNA decrease during treatment in primary HIV-1 infection with three different drug regimens : Italian Network of Acute HIV Infection (INACTION) clinical trial

enthalten in: Journal of medical virology | 2023

von Bruzzesi, E. | Gabrieli, A. | Bernasconi, D. | +12

6

First Pharmacokinetic Data of Tenofovir Alafenamide Fumarate and Tenofovir With Dolutegravir or Boosted Protease Inhibitors in African Children : A Substudy of the CHAPAS-4 Trial

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Waalewijn, H. | Szubert, A. | Wasmann, R. | +18

7

Population pharmacokinetics of unbound and total dolutegravir concentrations in children aged 12 years and older : a PK substudy of the SMILE trial

enthalten in: The Journal of antimicrobial chemotherapy | 2023

von Abdalla, S. | Compagnucci, A. | Zheng, Y. | +39

8

Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naïve (AMBER) and virologically suppressed (EMERALD) participants with neurological and/or psychiatric comorbidities : Week 96 subgroup analysis

enthalten in: HIV medicine | 2023

von Dunn, K. | Bushen, J. | Luo, D. | +3

9

Once-daily dolutegravir versus darunavir plus cobicistat in adults at the time of primary HIV-1 infection : the OPTIPRIM2-ANRS 169 randomized, open-label, Phase 3 trial

enthalten in: The Journal of antimicrobial chemotherapy | 2022

von Chéret, A. | Bauer, R. | Meiffrédy, V. | +12

10

Adaption of an ongoing clinical trial to quickly respond to gaps in changing international recommendations : the experience of D2EFT

enthalten in: HIV research & clinical practice | 2022

von Papot, E. | Jacoby, S. | Arlinda, D. | +22

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[16]